Use of floating alginate gel beads for stomach-specific drug delivery

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 50, Issue 2, 2000, Pages 221-226

  Murata, Y ^a   Sasaki, N ^a   Miyamoto, E ^a   Kawashima, S ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

Alginate gel bead; Chitosan; Floating; Intragastric drug delivery; Metronidazole

Indexed keywords

ALGINIC ACID; CHITOSAN; METRONIDAZOLE; VEGETABLE OIL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG RELEASE; DRUG TARGETING; GUINEA PIG; NONHUMAN; STOMACH JUICE; STOMACH MUCOSA; SUSTAINED RELEASE PREPARATION; TISSUE SPECIFICITY;

ALGINATES; ANIMALS; ANTI-INFECTIVE AGENTS; CHITIN; CHITOSAN; DRUG DELIVERY SYSTEMS; GASTRIC MUCOSA; GELS; GLUCURONIC ACID; GUINEA PIGS; HEXURONIC ACIDS; MALE; METRONIDAZOLE; SOLUBILITY;

EID: 0033848185     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(00)00110-7     Document Type: Article

References (15)

1. A. Kikuchi, M. Kawabuchi, M. Sugihara, Y. Sakurai, T. Okano, Pulsed dextran release from calcium-alginate gel beads, J. Control. Release 47 (1997) 21-29.
2. O. Gaserod, I.G. Jolliffe, F.C. Hampson, P.W. Dettmar, G. Skjak-Braek, The enhancement of the bioadhesive properties of calcium alginate gel beads by coating with chitosan, Int. J. Pharm. 175 (1998) 237-246.
3. Y. Murata, S. Toniwa, E. Miyamoto, S. Kawashima, Preparation of alginate gel beads containing chitosan nicotinic acid salt and the functions, Eur. J. Pharm. Biopharm. 48 (1999) 49-52.
4. A.J. Moes, Gastroretentive dosage forms, Crit. Rev. Ther. Drug Carrier System 10 (1993) 143-195.
5. M.R.J. Castellanos, H. Zia, C.T. Rhodes, Design and testing in vitro of bioadhesive and floating drug delivery system for oral application, Int. J. Pharm. 105 (1994) 65-70.
6. H. Katayama, T. Nishimura, S. Ochi, Y. Tsuruta, Y. Yamazaki, K. Shibata, H. Yoshitomi, Sustained release liquid preparation using sodium alginate for eradication of Helicobacter pylori, Biol. Pharm. Bull. 22 (1999) 55-60.
7. M. Ichikawa, S. Watanabe, Y. Miyake, A new multiple-unit oral floating dosage system. I: Preparation and in vitro evaluation of floating and sustained-release characteristics, J. Pharm. Sci. 80 (1991) 1062-1066.
8. S. Desai, S. Bolton, A floating controlled-release drug delivery system: in vitro-in vivo evaluation, Pharm. Res. 10 (1993) 1321-1325.
9. L. Whitehead, J.T. Fell, J.H. Sharma, A.M. Smith, Floating dosage forms: an in vivo study demonstrating prolonged gastric retention, J. Control. Release 55 (1998) 3-12.
10. M. Sorberg, H. Hanberger, M. Nilsson, A. Bjorkman, L.E. Nilsson, Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori, Antimicrob. Agents Chemother. 42 (1998) 1222-1228.
11. K. Lanbeck, B. Lindstrom, Determination of metronidazole and tinidazole in plasma and feces by high-performance liquid chromatography, J. Chromatogr. 162 (1979) 117-121.
12. T.U. Westblom, D.E. Duriex, E. Madan, R.B. Belshe, Guinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori following two separate dose regimens, Antimicrob. Agents Chemother. 34 (1990) 25-28.
13. J.W. Skoug, M.V. Mikelsons, C.N. Vigneron, N.L. Stemm, Qualitative evaluation of the mechanism of release of matrix sustained release dosage forms by measurement of polymer release, J. Control. Release 27 (1993) 227-245.
14. L. Yang, J. Eshraghi, R. Fassihi, A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: in vitro evaluation, J. Control. Release 57 (1999) 215-222.
15. S. Shah, R. Qaqish, V. Patel, M. Amiji, Evaluation of the factors influencing stomach-specific delivery of antibacterial agents for Helicobacter pylori infection, J. Pharm. Pharmacol. 51 (1999) 667-672.